Verus Capital Partners »

Regeneron Pharmaceuticals shares owned by Verus Capital Partners

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Verus Capital Partners from 13F filings

Historical chart of Verus Capital Partners investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Verus Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Verus Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $228k 259 878.29
2023-09-30 $235k 285 822.96
2023-06-30 $208k 290 718.54
2023-03-31 $263k 320 821.67
2022-09-30 $258k 375 688.00
2022-06-30 $252k 425 592.94
2022-03-31 $364k 560 650.00
2020-03-31 $38k 78 487.18
2019-12-31 $90k 240 375.00